title: Update on infantile hemangiomas.
abstract: Infantile hemangiomas are the most common tumors of infancy. The serendipitous discovery of the therapeutic efficacy of propranolol in the management of infantile hemangiomas has revolutionized the care and understanding of these lesions, and greatly improved the prognosis for a good cosmetic outcome. In addition, there has been an expansion of indications for treatment of hemangiomas, taking into account not only those hemangiomas that can cause airway compromise, amblyopia, and cardiac overload, but also those lesions that can lead to unsatisfactory cosmetic outcome or deformity after involution. Current concepts of pathogenesis of infantile hemangiomas, of segmental hemangiomas with systemic associations, of hepatic hemangiomas, and of the use of systemic and topical beta-blockers for the management of IH are all reviewed.
authors: Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI 02903, USA.
authors: Kachiu C
authors: KC
authors: Lee
authors: Lionel
authors: L
authors: Bercovitch
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D005260:Female; D018324:Hemangioma, Capillary / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009386:Neoplastic Syndromes, Hereditary / Q000175:diagnosis; D011379:Prognosis; D011433:Propranolol / Q000008:administration & dosage*; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol